1
|
Capaldo L, Wen Z, Noël T. A field guide to flow chemistry for synthetic organic chemists. Chem Sci 2023; 14:4230-4247. [PMID: 37123197 PMCID: PMC10132167 DOI: 10.1039/d3sc00992k] [Citation(s) in RCA: 77] [Impact Index Per Article: 38.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Accepted: 03/15/2023] [Indexed: 03/17/2023] Open
Abstract
Flow chemistry has unlocked a world of possibilities for the synthetic community, but the idea that it is a mysterious "black box" needs to go. In this review, we show that several of the benefits of microreactor technology can be exploited to push the boundaries in organic synthesis and to unleash unique reactivity and selectivity. By "lifting the veil" on some of the governing principles behind the observed trends, we hope that this review will serve as a useful field guide for those interested in diving into flow chemistry.
Collapse
Affiliation(s)
- Luca Capaldo
- Flow Chemistry Group, Van 't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam 1098 XH Amsterdam The Netherlands
| | - Zhenghui Wen
- Flow Chemistry Group, Van 't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam 1098 XH Amsterdam The Netherlands
| | - Timothy Noël
- Flow Chemistry Group, Van 't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam 1098 XH Amsterdam The Netherlands
| |
Collapse
|
2
|
McMullen JP, Wyvratt BM. Automated optimization under dynamic flow conditions. REACT CHEM ENG 2023. [DOI: 10.1039/d2re00256f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Abstract
The combination of feedback optimization with dynamic operations leads to enhanced data-rich experimentation in flow.
Collapse
Affiliation(s)
| | - Brian M. Wyvratt
- Merck & Co., Inc., 26 East Lincoln Avenue, Rahway, NJ, 07065, USA
| |
Collapse
|
3
|
Wietelmann U, Klösener J, Rittmeyer P, Schnippering S, Bats H, Stam W. Continuous Processing of Concentrated Organolithiums in Flow Using Static and Dynamic Spinning Disc Reactor Technologies. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.2c00007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Ulrich Wietelmann
- Albemarle Germany GmbH, Industrial Park Hoechst, D-65926 Frankfurt am Main, Germany
| | - Johannes Klösener
- Albemarle Germany GmbH, Industrial Park Hoechst, D-65926 Frankfurt am Main, Germany
| | - Peter Rittmeyer
- Albemarle Germany GmbH, Industrial Park Hoechst, D-65926 Frankfurt am Main, Germany
| | - Stefan Schnippering
- Albemarle Germany GmbH, Industrial Park Hoechst, D-65926 Frankfurt am Main, Germany
| | - Henk Bats
- Flowid, Achtseweg Zuid 157C, NL-5651 GW Eindhoven, The Netherlands
| | - Wouter Stam
- Flowid, Achtseweg Zuid 157C, NL-5651 GW Eindhoven, The Netherlands
| |
Collapse
|
4
|
Kang JH, Ahn GN, Lee H, Yim SJ, Lahore S, Lee HJ, Kim H, Kim JT, Kim DP. Scalable Subsecond Synthesis of Drug Scaffolds via Aryllithium Intermediates by Numbered-up 3D-Printed Metal Microreactors. ACS CENTRAL SCIENCE 2022; 8:43-50. [PMID: 35106371 PMCID: PMC8796307 DOI: 10.1021/acscentsci.1c00972] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Indexed: 05/10/2023]
Abstract
Continuous-flow microreactors enable ultrafast chemistry; however, their small capacity restricts industrial-level productivity of pharmaceutical compounds. In this work, scale-up subsecond synthesis of drug scaffolds was achieved via a 16 numbered-up printed metal microreactor (16N-PMR) assembly to render high productivity up to 20 g for 10 min operation. Initially, ultrafast synthetic chemistry of unstable lithiated intermediates in the halogen-lithium exchange reactions of three aryl halides and subsequent reactions with diverse electrophiles were carried out using a single microreactor (SMR). Larger production of the ultrafast synthesis was achieved by devising a monolithic module of 4 numbered-up 3D-printed metal microreactor (4N-PMR) that was integrated by laminating four SMRs and four bifurcation flow distributors in a compact manner. Eventually, the 16N-PMR system for the scalable subsecond synthesis of three drug scaffolds was assembled by stacking four monolithic modules of 4N-PMRs.
Collapse
Affiliation(s)
- Ji-Ho Kang
- Center
for Intelligent Microprocess of Pharmaceutical Synthesis, Department
of Chemical Engineering, Pohang University
of Science and Technology (POSTECH), Pohang 790-784, Republic of Korea
| | - Gwang-Noh Ahn
- Center
for Intelligent Microprocess of Pharmaceutical Synthesis, Department
of Chemical Engineering, Pohang University
of Science and Technology (POSTECH), Pohang 790-784, Republic of Korea
| | - Heekwon Lee
- Department
of Mechanical Engineering, The University
of Hong Kong, Pokfulam Road, Hong Kong, China
| | - Se-Jun Yim
- Center
for Intelligent Microprocess of Pharmaceutical Synthesis, Department
of Chemical Engineering, Pohang University
of Science and Technology (POSTECH), Pohang 790-784, Republic of Korea
| | - Santosh Lahore
- Center
for Intelligent Microprocess of Pharmaceutical Synthesis, Department
of Chemical Engineering, Pohang University
of Science and Technology (POSTECH), Pohang 790-784, Republic of Korea
| | - Hyune-Jea Lee
- Department
of Chemistry, College of Science, Korea
University, Seoul 02841, Republic of Korea
| | - Heejin Kim
- Department
of Chemistry, College of Science, Korea
University, Seoul 02841, Republic of Korea
| | - Ji Tae Kim
- Department
of Mechanical Engineering, The University
of Hong Kong, Pokfulam Road, Hong Kong, China
| | - Dong-Pyo Kim
- Center
for Intelligent Microprocess of Pharmaceutical Synthesis, Department
of Chemical Engineering, Pohang University
of Science and Technology (POSTECH), Pohang 790-784, Republic of Korea
| |
Collapse
|
5
|
Knochel P, Djukanovic D, Heinz B, Mandrelli F, Mostarda S, Filipponi P, Martin B. Continuous Flow Acylation of (Hetero)aryllithiums with Polyfunctional N,N-Dimethylamides and Tetramethylurea in Toluene. Chemistry 2021; 27:13977-13981. [PMID: 34387898 PMCID: PMC8519161 DOI: 10.1002/chem.202102805] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2021] [Indexed: 11/05/2022]
Abstract
The continuous flow reaction of various aryl or heteroaryl bromides in toluene in the presence of THF (1.0 equiv) with sec -BuLi (1.1 equiv) provided at 25 °C within 40 sec the corresponding aryllithiums which were acylated with various functionalized N,N-dimethylamides including easily enolizable amides at -20 °C within 27 sec, producing highly functionalized ketones in 48-90% yield (36 examples). This method was well suited for the preparation of α-chiral ketones such as naproxene and ibuprofen derived ketones with 99% ee . A one-pot stepwise bis-addition of two different lithium organometallics to 1,1,3,3-tetramethyurea (TMU) provided unsymmetrical ketones in 69-79% yield (9 examples).
Collapse
Affiliation(s)
- Paul Knochel
- Ludwig-Maximilians-Universitat Munchen, Department of Chemistry, Butenandtstr. 5-13, 81377, München, GERMANY
| | - Dimitrije Djukanovic
- Ludwig Maximillians University Munich: Ludwig-Maximilians-Universitat Munchen, Chemistry, GERMANY
| | - Benjamin Heinz
- Ludwig Maximillians University Munich: Ludwig-Maximilians-Universitat Munchen, Chemistry, GERMANY
| | | | - Serena Mostarda
- Novartis Pharma Schweiz AG, Chemical Development, SWITZERLAND
| | - Paolo Filipponi
- Novartis Pharma Schweiz AG, Chemical Development, SWITZERLAND
| | - Benjamin Martin
- Novartis Pharma Schweiz AG, Chemical Development, SWITZERLAND
| |
Collapse
|
6
|
Abstract
In the past decade, the field of organic synthesis has witnessed tremendous advancements in the areas of photoredox catalysis, electrochemistry, C-H activation, reductive coupling and flow chemistry. While these methods and technologies offer many strategic advantages in streamlining syntheses, their application on the process scale is complicated by several factors. In this Review, we discuss the challenges that arise when these reaction classes and/or flow chemistry technology are taken from a research laboratory operating at the milligram scale to a reactor capable of producing kilograms of product. We discuss how these challenges have been overcome through chemical and engineering solutions. Specifically, this Review will highlight key examples that have led to the production of multi-hundred-gram to kilogram quantities of active pharmaceutical ingredients or their intermediates and will provide insight on the scaling-up process to those developing new technologies and reactions.
Collapse
|
7
|
|
8
|
Scaling continuous API synthesis from milligram to kilogram: extending the enabling benefits of micro to the plant. J Flow Chem 2020. [DOI: 10.1007/s41981-019-00060-x] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
9
|
Rivera NR, Kassim B, Grigorov P, Wang H, Armenante M, Bu X, Lekhal A, Variankaval N. Investigation of a Flow Step Clogging Incident: A Precautionary Note on the Use of THF in Commercial-Scale Continuous Process. Org Process Res Dev 2019. [DOI: 10.1021/acs.oprd.9b00366] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
10
|
|
11
|
Bogdan AR, Dombrowski AW. Emerging Trends in Flow Chemistry and Applications to the Pharmaceutical Industry. J Med Chem 2019; 62:6422-6468. [DOI: 10.1021/acs.jmedchem.8b01760] [Citation(s) in RCA: 110] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Andrew R. Bogdan
- Discovery Chemistry and Technology, AbbVie, Inc. 1 North Waukegan Road, North Chicago, Illinois 60064, United States
| | - Amanda W. Dombrowski
- Discovery Chemistry and Technology, AbbVie, Inc. 1 North Waukegan Road, North Chicago, Illinois 60064, United States
| |
Collapse
|
12
|
Dunn AL, Leitch DC, Journet M, Martin M, Tabet EA, Curtis NR, Williams G, Goss C, Shaw T, O’Hare B, Wade C, Toczko MA, Liu P. Selective Continuous Flow Iodination Guided by Direct Spectroscopic Observation of Equilibrating Aryl Lithium Regioisomers. Organometallics 2019. [DOI: 10.1021/acs.organomet.8b00538] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Anna L. Dunn
- API Chemistry, GlaxoSmithKline, King of Prussia, Pennsylvania 19406, United States
| | - David C. Leitch
- API Chemistry, GlaxoSmithKline, King of Prussia, Pennsylvania 19406, United States
| | - Michel Journet
- API Chemistry, GlaxoSmithKline, King of Prussia, Pennsylvania 19406, United States
| | - Michael Martin
- Early Development Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina 27709, United States
| | - Elie A. Tabet
- Early Development Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina 27709, United States
| | | | | | - Charles Goss
- Process Analytical Technologies, GlaxoSmithKline, King of Prussia, Pennsylvania 19406, United States
| | - Tony Shaw
- API Chemistry, GlaxoSmithKline, King of Prussia, Pennsylvania 19406, United States
| | - Bernie O’Hare
- Global Spectroscopy, GlaxoSmithKline, King of Prussia, Pennsylvania 19406, United States
| | - Charles Wade
- API Chemistry, GlaxoSmithKline, Stevenage, U.K. SG1 2NY
| | - Matthew A. Toczko
- Early Development Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina 27709, United States
| | - Peng Liu
- API Chemistry, GlaxoSmithKline, King of Prussia, Pennsylvania 19406, United States
| |
Collapse
|
13
|
Wyvratt BM, McMullen JP, Grosser ST. Multidimensional dynamic experiments for data-rich process development of reactions in flow. REACT CHEM ENG 2019. [DOI: 10.1039/c9re00078j] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
The use of multidimensional dynamic flow experiments for reaction profiling and generation of an empirical surface response model for a Knoevenagel condensation reaction is described.
Collapse
|
14
|
McWilliams JC, Allian AD, Opalka SM, May SA, Journet M, Braden TM. The Evolving State of Continuous Processing in Pharmaceutical API Manufacturing: A Survey of Pharmaceutical Companies and Contract Manufacturing Organizations. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00160] [Citation(s) in RCA: 53] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- J. Christopher McWilliams
- Chemical Research and Development, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Ayman D. Allian
- Department of Pivotal Drug Substance Technologies, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States
| | - Suzanne M. Opalka
- Chemical Process Development, Biogen Idec, 115 Broadway, Cambridge, Massachusetts 02142, United States
| | - Scott A. May
- Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, Indiana 46285, United States
| | - Michel Journet
- API Chemistry, GSK, 709 Swedeland Road, UW2810, P.O. Box 1539, King of Prussia, Pennsylvania 19406, United States
| | - Timothy M. Braden
- Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, Indiana 46285, United States
| |
Collapse
|
15
|
McMullen JP, Marton CH, Sherry BD, Spencer G, Kukura J, Eyke NS. Development and Scale-Up of a Continuous Reaction for Production of an Active Pharmaceutical Ingredient Intermediate. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00192] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Jonathan P. McMullen
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Christopher H. Marton
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Benjamin D. Sherry
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Glenn Spencer
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Joseph Kukura
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Natalie S. Eyke
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| |
Collapse
|
16
|
Lévesque F, Rogus NJ, Spencer G, Grigorov P, McMullen JP, Thaisrivongs DA, Davies IW, Naber JR. Advancing Flow Chemistry Portability: A Simplified Approach to Scaling Up Flow Chemistry. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00063] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Affiliation(s)
- François Lévesque
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Nicholas J. Rogus
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Glenn Spencer
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Plamen Grigorov
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Jonathan P. McMullen
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - David A. Thaisrivongs
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Ian W. Davies
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - John R. Naber
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| |
Collapse
|
17
|
Hunter SM, Susanne F, Whitten R, Hartwig T, Schilling M. Process design methodology for organometallic chemistry in continuous flow systems. Tetrahedron 2018. [DOI: 10.1016/j.tet.2018.04.020] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
18
|
Thaisrivongs DA, Morris WJ, Tan L, Song ZJ, Lyons TW, Waldman JH, Naber JR, Chen W, Chen L, Zhang B, Yang J. A Next Generation Synthesis of BACE1 Inhibitor Verubecestat (MK-8931). Org Lett 2018; 20:1568-1571. [DOI: 10.1021/acs.orglett.8b00259] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- David A. Thaisrivongs
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - William J. Morris
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Lushi Tan
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Zhiguo J. Song
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Thomas W. Lyons
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Jacob H. Waldman
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - John R. Naber
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Wenyong Chen
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Lu Chen
- WuXi AppTec (Shanghai) Pharmaceutical Co. Ltd., 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China
| | - Baoyun Zhang
- WuXi AppTec (Shanghai) Pharmaceutical Co. Ltd., 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China
| | - Jun Yang
- WuXi AppTec (Shanghai) Pharmaceutical Co. Ltd., 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China
| |
Collapse
|
19
|
Thaisrivongs DA, Naber JR, Rogus NJ, Spencer G. Development of an Organometallic Flow Chemistry Reaction at Pilot-Plant Scale for the Manufacture of Verubecestat. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.7b00385] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- David A. Thaisrivongs
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - John R. Naber
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Nicholas J. Rogus
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Glenn Spencer
- Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
| |
Collapse
|
20
|
Barhate CL, Lopez DA, Makarov AA, Bu X, Morris WJ, Lekhal A, Hartman R, Armstrong DW, Regalado EL. Macrocyclic glycopeptide chiral selectors bonded to core-shell particles enables enantiopurity analysis of the entire verubecestat synthetic route. J Chromatogr A 2018; 1539:87-92. [PMID: 29397980 DOI: 10.1016/j.chroma.2018.01.042] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2017] [Revised: 01/18/2018] [Accepted: 01/19/2018] [Indexed: 01/01/2023]
Abstract
Verubecestat is an inhibitor of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) being evaluated in clinical trials for the treatment of Alzheimer's disease. Synthetic route development involves diastereoselective transformations with a need for enantiomeric excess (ee) determination of each intermediate and final active pharmaceutical ingredient (API). The analytical technical package of validated methods relies on enantioselective SFC and RPLC separations using multiple 3 and 5 μm coated polysaccharide-based chiral stationary phases (CSPs) and mobile phases combinations. Evaluation of recently developed chiral columns revealed a single chiral selector (Teicoplanin) bonded to 2.7 μm core-shell particles using H3PO4 in H2O/ACN and triethylammonium acetate: methanol based eluents at different isocratic compositions allowed good enatioseparation of all verubecestat intermediates. EE determination of verubecestat is easily performed on NicoShell, another macrocyclic glycopeptide chiral selector bonded to 2.7 μm superficially porous particles. This approach enables fast and reliable enantiopurity analysis of the entire verubecestat synthetic route using only two chiral columns and mobile phases on a conventional HPLC system, simplifying technical package preparation, method validation and transfer to manufacturing facilities.
Collapse
Affiliation(s)
- Chandan L Barhate
- Department of Chemistry, University of Texas at Arlington, Arlington, TX 76019, USA
| | - Diego A Lopez
- Department of Chemistry, University of Texas at Arlington, Arlington, TX 76019, USA
| | - Alexey A Makarov
- Process Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Xiaodong Bu
- Process Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - William J Morris
- Process Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Azzeddine Lekhal
- Process Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Robert Hartman
- Process Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Daniel W Armstrong
- Department of Chemistry, University of Texas at Arlington, Arlington, TX 76019, USA
| | - Erik L Regalado
- Process Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA.
| |
Collapse
|
21
|
Cole KP, Johnson MD. Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds. Expert Rev Clin Pharmacol 2017; 11:5-13. [DOI: 10.1080/17512433.2018.1413936] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Kevin P. Cole
- Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN, USA
| | - Martin D. Johnson
- Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN, USA
| |
Collapse
|
22
|
Susanne F, Martin B, Aubry M, Sedelmeier J, Lima F, Sevinc S, Piccioni L, Haber J, Schenkel B, Venturoni F. Match-Making Reactors to Chemistry: A Continuous Manufacturing-Enabled Sequence to a Key Benzoxazole Pharmaceutical Intermediate. Org Process Res Dev 2017. [DOI: 10.1021/acs.oprd.7b00254] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Flavien Susanne
- Novartis Pharma AG, Chemical and Analytical Development, Fabrikstrasse 14, 4002, Basel, Switzerland
| | - Benjamin Martin
- Novartis Pharma AG, Chemical and Analytical Development, Fabrikstrasse 14, 4002, Basel, Switzerland
| | - Michel Aubry
- Novartis Pharma AG, Chemical and Analytical Development, Fabrikstrasse 14, 4002, Basel, Switzerland
| | - Joerg Sedelmeier
- Novartis Pharma AG, Chemical and Analytical Development, Fabrikstrasse 14, 4002, Basel, Switzerland
| | - Fabio Lima
- Novartis Pharma AG, Chemical and Analytical Development, Fabrikstrasse 14, 4002, Basel, Switzerland
| | - Serbuelent Sevinc
- Novartis Pharma AG, Chemical and Analytical Development, Fabrikstrasse 14, 4002, Basel, Switzerland
| | - Lorenzo Piccioni
- Novartis Pharma AG, Chemical and Analytical Development, Fabrikstrasse 14, 4002, Basel, Switzerland
| | - Julien Haber
- Novartis Pharma AG, Chemical and Analytical Development, Fabrikstrasse 14, 4002, Basel, Switzerland
| | - Berthold Schenkel
- Novartis Pharma AG, Chemical and Analytical Development, Fabrikstrasse 14, 4002, Basel, Switzerland
| | - Francesco Venturoni
- Novartis Pharma AG, Chemical and Analytical Development, Fabrikstrasse 14, 4002, Basel, Switzerland
| |
Collapse
|
23
|
Plutschack MB, Pieber B, Gilmore K, Seeberger PH. The Hitchhiker's Guide to Flow Chemistry ∥. Chem Rev 2017; 117:11796-11893. [PMID: 28570059 DOI: 10.1021/acs.chemrev.7b00183] [Citation(s) in RCA: 1087] [Impact Index Per Article: 135.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Flow chemistry involves the use of channels or tubing to conduct a reaction in a continuous stream rather than in a flask. Flow equipment provides chemists with unique control over reaction parameters enhancing reactivity or in some cases enabling new reactions. This relatively young technology has received a remarkable amount of attention in the past decade with many reports on what can be done in flow. Until recently, however, the question, "Should we do this in flow?" has merely been an afterthought. This review introduces readers to the basic principles and fundamentals of flow chemistry and critically discusses recent flow chemistry accounts.
Collapse
Affiliation(s)
- Matthew B Plutschack
- Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces , Am Mühlenberg 1, 14476 Potsdam, Germany
| | - Bartholomäus Pieber
- Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces , Am Mühlenberg 1, 14476 Potsdam, Germany
| | - Kerry Gilmore
- Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces , Am Mühlenberg 1, 14476 Potsdam, Germany
| | - Peter H Seeberger
- Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces , Am Mühlenberg 1, 14476 Potsdam, Germany.,Institute of Chemistry and Biochemistry, Department of Biology, Chemistry and Pharmacy, Freie Universität Berlin , Arnimallee 22, 14195 Berlin, Germany
| |
Collapse
|
24
|
Recent Advances of Microfluidics Technologies in the Field of Medicinal Chemistry. ANNUAL REPORTS IN MEDICINAL CHEMISTRY 2017. [DOI: 10.1016/bs.armc.2017.09.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|